Related Experiment Videos
Fusidic acid non-antibacterial activity.
1Department of Microbiology and Infectious Diseases, Royal Perth Hospital, Western Australia, Australia. keryn.christiansen@rph.health.wa.gov.au
International Journal of Antimicrobial Agents
|October 21, 1999
Summary
Fusidic acid, an antibiotic, demonstrates immunomodulatory effects by impacting white blood cells and suppressing cytokine production. Its potential in treating immune-mediated diseases warrants further investigation.
Area of Science:
- Immunology
- Pharmacology
- Microbiology
Background:
- Fusidic acid's immunomodulatory properties were first reported in 1978.
- Initial studies focused on in vitro effects on white blood cells and in vivo survival in transplanted mice.
- By 1990, its immunomodulatory effects were linked to cytokine suppression in animal models.
Purpose of the Study:
- To explore the immunomodulatory potential of fusidic acid.
- To investigate the application of fusidic acid in various immune-mediated diseases.
- To determine the full therapeutic utility of fusidic acid as an immunomodulating agent.
Main Methods:
- In vitro studies on white blood cells.
- In vivo studies involving heart transplanted mice.
- Animal models of septic shock and insulin-dependent diabetes to assess cytokine production.
Main Results:
- Demonstrated immunomodulatory effects on white blood cells.
- Improved survival rates in heart transplanted mice.
- Suppression of cytokine production in animal models of disease.
Conclusions:
- Fusidic acid exhibits significant immunomodulatory capabilities.
- Its effects have been observed in various disease models, including septic shock and diabetes.
- Further research is needed to fully elucidate the therapeutic potential of fusidic acid in immune-mediated conditions.